Large-scale testing (Phase 3)Study completedNCT02446743What this trial is testingCombined Study - Phase 3b MenB Long Term Persistence in AdolescentsWho this might be right forInfections, Meningococcal GlaxoSmithKline 531
Large-scale testing (Phase 3)Study completedNCT02955797What this trial is testingImmunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in ToddlersWho this might be right forMeningitisMeningococcal MeningitisMeningococcal Infections Sanofi Pasteur, a Sanofi Company 918
Testing effectiveness (Phase 2)Study completedNCT00381615What this trial is testingPrevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy StudyWho this might be right forHealthy Novartis Vaccines 147
Post-approval studies (Phase 4)Study completedNCT01119482What this trial is testingStudy on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal CarriageWho this might be right forMeningitis London School of Hygiene and Tropical Medicine 33,000
Not applicableLooking for participantsNCT04664569What this trial is testingNational Bacterial Meningitis Study in Children and NewbornsWho this might be right forMeningitisChildren, OnlyPneumococcal Conjugate Vaccine+5 more Association Clinique Thérapeutique Infantile du val de Marne 10,000
Large-scale testing (Phase 3)Study completedNCT04819113What this trial is testingStudy to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of AgeWho this might be right forMeningococcal Vaccine Pfizer 149
Post-approval studies (Phase 4)Study completedNCT00119080What this trial is testingEffect of Meningococcal Conjugate Vaccine on Meningococcal CarriageWho this might be right forMeningitis Centers for Disease Control and Prevention 4,000
Large-scale testing (Phase 3)Study completedNCT04707391What this trial is testingImmunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY VaccineWho this might be right forMeningitis, Meningococcal GlaxoSmithKline 1,250
Large-scale testing (Phase 3)Study completedNCT01478347What this trial is testingA Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk AdultsWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 18
Testing effectiveness (Phase 2)Study completedNCT01367158What this trial is testingSafety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study VaccinesWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 440
Not applicableUnknownNCT04239430What this trial is testingPropositive (Protecting Positive People From Meningococcal Infection) Follow-up StudyWho this might be right forHIV/AIDSMeningococcal Disease St George's, University of London 55
Large-scale testing (Phase 3)Study completedNCT02173704What this trial is testingSafety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.Who this might be right forMeningococcal DiseaseInfections, Meningococcal GlaxoSmithKline 225
Testing effectiveness (Phase 2)Study completedNCT01897402What this trial is testingImmunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate VaccineWho this might be right forMeningococcal MeningitisMeningococcal Infections JN-International Medical Corporation 525
Large-scale testing (Phase 3)Looking for participantsNCT07710872What this trial is testingImmunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in ChinaWho this might be right forMeningococcal InfectionHealthy Volunteers Sanofi 4,568
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198What this trial is testingA Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of AgeWho this might be right forMeningitis, Meningococcal GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT00262002What this trial is testingStudy of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy InfantsWho this might be right forPrevention of Meningococcal Disease Novartis Vaccines 601
Testing effectiveness (Phase 2)Study completedNCT00356369What this trial is testingStudy in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate VaccineWho this might be right forInfections, Meningococcal GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT06128733What this trial is testingStudy of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and AdolescentsWho this might be right forMeningococcal ImmunisationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 1,215
Early research (Phase 1)Ended earlyNCT01164514What this trial is testingDetoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantWho this might be right forBacterial Sepsis National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Not Yet RecruitingNCT07374510What this trial is testingPhase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate VaccineWho this might be right forMeningococcal Meningitis Sinovac Life Sciences Co., Ltd. 150